Helix 51 Incubator Company BLR Bio Presents Promising New Scleroderma Drug Data at International Rheumatology Meeting
BLR Bio, a company in RFU’s Helix 51 incubator, recently presented new data at the 2026 British…
News Archive, Page 1: Filtered to Research
Rosalind Franklin University Incubator Company Presents Promising Glioblastoma Therapy Data at Major Brain Cancer Conference
A novel glioblastoma therapy developed by Rosalind Franklin University Helix 51 incubator company…
Keeping People Healthy in the 21st Century
Population health management is reshaping systems, environments and policies.
Philosophy 007
What do a doctorate of philosophy, proteomics and human relationships have in common?
Social Instability and the Amygdala
What happens when we disrupt social bonds
The Maternal–Fetal Interface
Decoding how immune and uterine cells communicate to build tolerance and sustain life.
National Cancer Institute Awards RFU Researcher Grant to Crack the Epigenetic Code of Pancreatic Cancer Muscle Wasting
Paige Arneson-Wissink, PhD, assistant professor of biochemistry and molecular biology in the Center…
RFU Researcher Awarded $1.9M NIH Grant for Neurological Disease Research
Hongkyun Kim, PhD, professor of cell biology and anatomy in Rosalind Franklin University’s Center for Cancer Cell Biology…
Startup gets state grant to develop brain cancer-fighting virus
A startup at the Helix 51 incubator at Rosalind Franklin University has been given an Illinois Innovation Voucher grant…
RFU Helix 51 Incubator Company Receives Grant for Cancer-Drug Development
UP Oncolytics, a biotech company in Rosalind Franklin University’s Helix 51 biomedical incubator, was awarded an Illinois…